The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight.

Atherosclerosis
Geesje M Dallinga-ThieMax Nieuwdorp

Abstract

Peripheral lipoprotein lipase (LPL)-mediated lipolysis of triglycerides is the first step in chylomicron/VLDL clearance involving heparan sulfate proteoglycans (HSPGs) displayed at the cell surface of the capillaries in adipose tissue, heart and skeletal muscle. The newly generated chylomicron remnant particles are then cleared by the liver, whereas VLDL remnant particles are either further modified, through the action of hepatic lipase (HL) and cholesteryl ester transfer protein (CETP), into LDL particles or alternatively directly cleared by the liver. Two proteins, lipase maturation factor 1 (LMF1) and glycosylphosphatidylinositol-anchored high density lipoprotein binding protein 1 (GPIHBP1), have been recently identified and have revised our current understanding of LPL maturation and LPL-mediated lipolysis. Moreover, new insights have been gained with respect to hepatic remnant clearance using genetically modified mice targeting the sulfation of HSPGs and even deletion of the most abundant heparan sulfate proteoglycan: syndecan1. In this review, we will provide an overview of novel data on both peripheral TG hydrolysis and hepatic remnant clearance that will improve our knowledge of plasma triglyceride metabolism.

References

Oct 15, 1992·The Biochemical Journal·J E Braun, D L Severson
Jan 1, 1991·Annual Review of Nutrition·A Bensadoun
May 1, 1989·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·S P BabirakJ D Brunzell
Jun 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·T KitaR J Havel
May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·J HerzR J Havel
Mar 1, 1997·Clinical and Experimental Pharmacology & Physiology·B C MortimerT G Redgrave
Feb 13, 1999·Journal of Protein Chemistry·O U BegA R Siddiqi
Apr 25, 2000·Biochemical and Biophysical Research Communications·A LookeneG Olivecrona
Mar 7, 2001·Frontiers in Bioscience : a Journal and Virtual Library·I J Goldberg, M Merkel
Jun 5, 2002·Annual Review of Biochemistry·Jeffrey D Esko, Scott B Selleck
Dec 14, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Claudio Priore OlivaSebastiano Calandra
May 10, 2005·The Journal of Biological Chemistry·Aivar LookeneRobert O Ryan
Dec 24, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Joerg HeerenThomas Grewal
Jun 6, 2006·Diabetologia·G M Dallinga-ThieUNKNOWN DALI study group
Nov 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Valentina SukoninaGunilla Olivecrona
Jan 4, 2007·The Journal of Clinical Investigation·Robert W Mahley, Yadong Huang
Jan 4, 2007·The Journal of Clinical Investigation·Christopher JonesHelen H Hobbs
Apr 27, 2007·Nature·Joseph R BishopJeffrey D Esko
Jul 11, 2007·Current Opinion in Lipidology·Stephen G YoungAnne P Beigneux
Jul 20, 2007·JAMA : the Journal of the American Medical Association·Børge G NordestgaardAnne Tybjaerg-Hansen
Nov 13, 2007·Nature Genetics·Miklós PéterfyMark H Doolittle
May 8, 2008·Current Opinion in Lipidology·Joseph R BishopJeffrey D Esko
May 30, 2008·Frontiers in Bioscience : a Journal and Virtual Library·Magnus KjaergaardMichael Ploug
Aug 21, 2008·The Journal of Biological Chemistry·Peter GinAnne P Beigneux
Sep 30, 2008·Cellular and Molecular Life Sciences : CMLS·A Galat
Oct 3, 2008·The Journal of Clinical Investigation·Kevin Jon Williams
Oct 11, 2008·The Journal of Biological Chemistry·Michael M WeinsteinStephen G Young
Mar 24, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Anne P BeigneuxStephen G Young

❮ Previous
Next ❯

Citations

Aug 5, 2010·Current Opinion in Lipidology·Gunilla Olivecrona, Thomas Olivecrona
Jan 6, 2011·Current Opinion in Lipidology·Ian S Young, D Paul Nicholls
Jun 14, 2012·Current Opinion in Lipidology·Daniel GaudetJohn Kastelein
Mar 5, 2013·Physiology·Carolina HagbergUlf Eriksson
Aug 2, 2011·American Journal of Respiratory and Critical Care Medicine·Luciano F DragerLuciano Polotsky
Jul 6, 2012·Journal of Lipid Research·Ratnesh Kumar SinghMarica Bakovic
Nov 3, 2010·Journal of Lipid Research·Christopher T JohansenRobert A Hegele
Apr 16, 2013·Nutrients·Boudewijn KlopManuel Castro Cabezas
Feb 11, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Jan BorénMarja-Riitta Taskinen
May 29, 2014·Clínica e investigación en arteriosclerosis : publicación oficial de la Sociedad Española de Arteriosclerosis·Marijke A de VriesManuel Castro Cabezas
Jun 17, 2014·Journal of Reproductive Immunology·Aafke P A van MontfoortUwe J F Tietge
Jan 1, 2014·Journal of Animal Science and Biotechnology·Jie YangLi Jiang
Sep 16, 2015·International Journal of Molecular Sciences·José Ángel Cahua-PabloEugenia Flores-Alfaro
Feb 13, 2016·Clinica Chimica Acta; International Journal of Clinical Chemistry·Josep JulveFrancisco Blanco-Vaca
Sep 25, 2012·Heart Failure Clinics·Jeong-a KimMichael J Quon
Mar 6, 2012·Molecular Immunology·Danny GauvreauKatherine Cianflone
Dec 20, 2011·Biochimica Et Biophysica Acta·H C HassingG M Dallinga-Thie
Oct 8, 2011·Biochimica Et Biophysica Acta·Laura K ColeDennis E Vance
Oct 26, 2011·Biochimica Et Biophysica Acta·Min Suk KimBrian Rodrigues
Jul 14, 2011·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A P van de WoestijneF L J Visseren
Mar 21, 2016·Biochimica Et Biophysica Acta·Amy Pei-Ling ChiuBrian Rodrigues
Sep 24, 2015·Glycoconjugate Journal·Astri J MeenSvein O Kolset
Oct 6, 2015·Trends in Pharmacological Sciences·Giuseppe Danilo NorataAlberico L Catapano
Mar 18, 2015·British Journal of Clinical Pharmacology·Bernhard F BeckerDaniel Chappell
Nov 20, 2012·Biochemical and Biophysical Research Communications·Shaikh M RahmanJacob E Friedman
Feb 24, 2015·Atherosclerosis·Marja-Riitta Taskinen, Jan Borén
Jun 19, 2013·Progress in Lipid Research·Kathleen M Botham, Caroline P D Wheeler-Jones
May 19, 2011·Biochimica Et Biophysica Acta·Renate SchreiberAchim Lass
Jul 23, 2014·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Lulu XiaKemin Qi
Jul 2, 2011·Journal of Hepatology·Margaret F BassendineR Dermot G Neely
Apr 2, 2013·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Sheila M Innis, Carolanne M Nelson
Dec 3, 2014·Biochimica Et Biophysica Acta·Ying Wang, Brian Rodrigues
Sep 21, 2013·Biochimica Et Biophysica Acta·Ursula Pieper-Fürst, Frank Lammert

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.